Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation symbols : Abeo save search
Abeona Therapeutics Announces Acceptance of Abstract on EB-101 Phase 3 VIITAL™ Study Results for Oral Presentation at International Societies for Investigative Dermatology (ISID) 2023 Meeting
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.29%
H: 3.52%
C: -0.78%
eb-101 presentation international meeting therapeutics study
Abeona Therapeutics Announces Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Published: 2022-04-29 (Crawled : 14:00) - biospace.com/
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 8.8%
H: 0.0%
C: -10.22%
research therapeutics presentation
Abeona Therapeutics Announces Presentation on Pivotal Transpher A Study of ABO-102 in MPS IIIA at the 14th ICIEM Conference
Published: 2021-11-17 (Crawled : 12:30) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -6.75%
H: 0.0%
C: 0.0%
presentation conference
Abeona Therapeutics to Present at Jefferies Gene Therapy/Editing Summit
Published: 2021-10-21 (Crawled : 12:00) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.31%
H: 4.66%
C: 2.83%
gene therapy therapy presentation therapeutics
Abeona Therapeutics Announces Clinical Data Presentations at Upcoming Scientific Congresses
Published: 2021-10-13 (Crawled : 12:00) - biospace.com/
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -0.82%
H: 3.37%
C: -1.09%
presentation therapeutics
Abeona Therapeutics to Present at Upcoming Investor Conferences
Published: 2021-09-07 (Crawled : 12:00) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 0.38%
H: 2.26%
C: -3.01%
conference presentation therapeutics
Abeona Therapeutics to Present at Jefferies Virtual Healthcare Conference
Published: 2021-06-02 (Crawled : 12:00) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 0.58%
H: 2.91%
C: 2.33%
conference presentation therapeutics
Abeona Therapeutics Announces Presentation on New Preclinical Data Supporting the Potential of Cre-Mediated Dual AAV Vector Technology to Enable Delivery of Large Genes Targeted for Treatment of Stargardt Disease at ARVO 2021 Annual Meeting
Published: 2021-04-20 (Crawled : 12:00) - globenewswire.com
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.84%
H: 8.03%
C: 6.57%
presentation disease media treatment potential technology liver aav9 preclinical pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.